May 20, 2020 / 9:23 AM / 10 days ago

BRIEF-ArcticZymes Gets Funding From Innovation Norway

May 20 (Reuters) - Biotec Pharmacon ASA:

* ARCTICZYMES GRANTED NOK 1.65 MILLION FUNDING FROM INNOVATION NORWAY FOR A SAN-HQ UPSCALING PROJECT

* ARCTICZYMES HAS BEEN GRANTED UP TO NOK 1.65 MILLION FOR A PROJECT TO INCREASE MANUFACTURING SCALE OF ITS SAN-HQ ENZYME

* SUPPLY OF SAN-HQ HAS POTENTIAL TO BE EXPANDED INTO OUR PARTNERS DEVELOPING VIRAL BASED VACCINES AGAINST COVID-19

* PROJECT WILL ACCELERATE ONGOING EFFORTS TO SCALE PRODUCTION CAPACITY AND IS ESTIMATED TO BE COMPLETED WITHIN 8-10 MONTHS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below